<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Atrial natriuretic <z:chebi fb="7" ids="16670">peptide</z:chebi> (ANP), whose amyloid is responsible of isolated atrial <z:hpo ids='HP_0011034'>amyloidosis</z:hpo> (<z:mp ids='MP_0004157'>IAA</z:mp>), is known to play an important role in the pathophysiology of <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>We provide here the microscopic examination of atrial biopsies from 36 young (mean 40 years) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> patients distinguished in idiopathic <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> (DC) affected and <z:hpo ids='HP_0001639'>hypertrophic Cardiomyopathy</z:hpo> (HC) affected, endorsing the presumptive association of early <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> with <z:mp ids='MP_0004157'>IAA</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>We utilized a multiple method, using <z:chebi fb="0" ids="34653">Congo red</z:chebi> (CR) staining, CR fluorescence (CRF), and immunohistochemistry to assess the presence of <z:mp ids='MP_0004157'>IAA</z:mp> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Immunostaining showed a moderate deposition of <z:mp ids='MP_0004157'>IAA</z:mp> in the atrium surrounding working myocardium with small intracellular deposits </plain></SENT>
<SENT sid="4" pm="."><plain>Our findings suggest a monitoring of young <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> cases for the development of <z:mp ids='MP_0004157'>IAA</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Our study also demonstrated how the concurrent use of immunohistochemistry, CR, and CRF may greatly enhance the detection of low-grade amyloid deposits </plain></SENT>
</text></document>